Showing results (141-150 of 367) with videos related to

Sort By:
Pageof 37
Cardiovascular Diabetology|November 27, 2020
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trialJoão Pedro Ferreira, Subodh Verma, David Fitchett, et al.
CJC Open|January 7, 2022
A Novel Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Biomarker-Anti-DSG2-Is Absent in Athletes With Right Ventricular EnlargementDavid Dorian, Diptendu Chatterjee, Kim A Connelly, et al.
Magnetic Resonance in Medicine|June 25, 2010
Rapid multislice imaging of hyperpolarized 13C pyruvate and bicarbonate in the heartAngus Z Lau, Albert P Chen, Nilesh R Ghugre, et al.
The Canadian Journal of Cardiology|October 4, 2011
Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus ConferenceG B John Mancini, Steven Baker, Jean Bergeron, et al.
Diabetes|May 19, 2012
Early-outgrowth bone marrow cells attenuate renal injury and dysfunction via an antioxidant effect in a mouse model of type 2 diabetesYanling Zhang, Darren A Yuen, Andrew Advani, et al.
Circulation. Heart Failure|October 8, 2009
Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathyKim A Connelly, Darren J Kelly, Yuan Zhang, et al.
Nephrology (Carlton, Vic.)|December 23, 2021
Assessments of right ventricular strain using cardiac magnetic resonance imaging following kidney transplantationSean Cai, Tahrin Mahmood, Abdulaziz Ahmed Hashi, et al.
Cardiovascular Research|October 20, 2021
Pannexin 1: a novel regulator of acute hypoxic pulmonary vasoconstrictionBenjamin Grimmer, Adrienn Krauszman, Xudong Hu, et al.
ESC Heart Failure|April 11, 2023
Impact of diabetes duration on left ventricular mass regression with empagliflozinMichael Moroney, Raj Verma, Makoto Hibino, et al.
ESC Heart Failure|April 11, 2023
Baseline neutrophil-to-lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodellingRaj Verma, Michael Moroney, Makoto Hibino, et al.
Pageof 37